Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 1
1990 3
1991 2
1992 2
1993 1
1994 3
1995 3
1996 5
1997 7
1998 10
1999 18
2000 20
2001 16
2002 7
2003 10
2004 11
2005 10
2006 7
2007 8
2008 6
2009 20
2010 15
2011 28
2012 24
2013 32
2014 44
2015 55
2016 77
2017 80
2018 67
2019 47
2020 13
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21903982

589 results
Results by year
Filters applied: . Clear all
Page 1
Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Hart RG, Pearce LA, Asinger RW, Herzog CA. Hart RG, et al. Clin J Am Soc Nephrol. 2011 Nov;6(11):2599-604. doi: 10.2215/CJN.02400311. Epub 2011 Sep 8. Clin J Am Soc Nephrol. 2011. PMID: 21903982 Free PMC article. Clinical Trial.
Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
Eikelboom JW, Connolly SJ, Gao P, Paolasso E, De Caterina R, Husted S, O'Donnell M, Yusuf S, Hart RG. Eikelboom JW, et al. J Stroke Cerebrovasc Dis. 2012 Aug;21(6):429-35. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.007. J Stroke Cerebrovasc Dis. 2012. PMID: 22818021 Clinical Trial.
Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benítez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elízaga J, Dager A, García Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodés-Cabau J. Abdul-Jawad Altisent O, et al. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1706-17. doi: 10.1016/j.jcin.2016.06.025. JACC Cardiovasc Interv. 2016. PMID: 27539691 Free article.
Novel oral anticoagulants in atrial fibrillation: a meta-analysis of large, randomized, controlled trials vs warfarin.
Dogliotti A, Paolasso E, Giugliano RP. Dogliotti A, et al. Clin Cardiol. 2013 Feb;36(2):61-7. doi: 10.1002/clc.22081. Epub 2013 Jan 21. Clin Cardiol. 2013. PMID: 23338902 Free PMC article. Review.
Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
Kuo L, Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Lip GYH, Chen SA. Kuo L, et al. J Am Heart Assoc. 2017 Jun 23;6(6):e005307. doi: 10.1161/JAHA.116.005307. J Am Heart Assoc. 2017. PMID: 28645935 Free PMC article.
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Patel MR, et al. J Am Coll Cardiol. 2013 Feb 12;61(6):651-8. doi: 10.1016/j.jacc.2012.09.057. J Am Coll Cardiol. 2013. PMID: 23391196 Free article. Clinical Trial.
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.
Lee KH, Park HW, Lee N, Hyun DY, Won J, Oh SS, Park HJ, Kim Y, Cho JY, Kim MC, Sim DS, Yoon HJ, Yoon NS, Kim KH, Hong YJ, Kim JH, Ahn Y, Jeong MH, Park JC, Cho JG. Lee KH, et al. Europace. 2017 Dec 1;19(suppl_4):iv1-iv9. doi: 10.1093/europace/eux247. Europace. 2017. PMID: 29220421
Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Gulløv AL, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J, Boysen G. Gulløv AL, et al. Arch Intern Med. 1998 Jul 27;158(14):1513-21. doi: 10.1001/archinte.158.14.1513. Arch Intern Med. 1998. PMID: 9679792 Clinical Trial.
Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators. Flaker GC, et al. Am Heart J. 2006 Nov;152(5):967-73. doi: 10.1016/j.ahj.2006.06.024. Am Heart J. 2006. PMID: 17070169
589 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback